Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections

Journal of Infectious Diseases

Volumn 187, Issue 9, 2003, Pages 1452-1459

  Laupland, Kevin B ^a,b   Church, Deirdre L ^a,b   Mucenski, Melissa ^a   Sutherland, Lloyd R ^a   Davies, H Dele ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANADA; FATALITY; FEMALE; GENDER; HEMODIALYSIS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGING; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; SEX CHARACTERISTICS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0038217024     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374621     Document Type: Article

References (43)

1. Lowy F. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
2. Richards M, Edwards J, Culver D, Gaynes R. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-92.
3. Vincent JL, Bihari D, Suter P, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274:639-44.
4. Steinberg J, Clark C, Hackman B. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996; 23:255-9.
5. O'Kane G, Gottlieb T, Bradbury R. Staphylococcal bacteraemia: the hospital or home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993. Aust N Z J Med 1998; 28:23-7.
6. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100:509-16.
7. Weinke T, Schiller R, Fehrenbach F, Pohle H. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992; 11:985-9.
8. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344:11-6.
9. Smith T, Pearson M, Wilcox K, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340:493-501.
10. Sieradzki K, Roberts R, Haber S, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340:517-23.
11. Morin C, Hadler J. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001; 184:1029-34.
12. Jensen A, Wachmann C, Poulsen K, et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999; 159:1437-44.
13. Kaandorp C, Dinant H, vandeLaar M, Bernelot Moens H, Prins A, Dijkmans B. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997; 56:470-5.
14. Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker D. All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's results. J Hosp Infect 1999; 41:173-9.
15. Church D, Hall P. Centralization of a regional clinical microbiology service: the Calgary experience. Can J Infect Dis 1999; 10:393-402.
16. Garner J, Jarvis W, Emori T, Horan T, Hughes J. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard. 7th ed. NCCLS document M2-A7, vol. 20 no. 1. Villanova, PA: National Committee for Clinical Laboratory Standards, 2000.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: eighth informational supplement. NCCLS document M100-S8, vol. 18 no. 1. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
19. Pfaller M. Detection of methicillin resistance in staphylococci by PCR (section 10.5.3). In: Isenberg H, ed. Essential procedures for clinical microbiology. Washington, DC: American Society for Microbiology, 1998:666-8.
20. Southern Alberta Clinic. Available at: http://www.crha-health.ab.ca/clin/sac/epidprov.htm.
21. Manns B, Mortis G, Taub K, McLaughlin K, Donaldson C, Ghali W. The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med 2001; 24:164-70.
22. Laupland K, Zygun D, Davies H, Church D, Louie T, Doig C. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 2002; 17:50-7.
23. National Population Health Survey. Available at: http://www.acs.ucalgary.ca/cgi-bin/landru.
24. Mao Y, Morrsion H, Semenciw R, Robson D, Wigle D. The prevalence of cancer in Canada. Can J Public Health 1991; 82:61-2.
25. Gabriel S, Crowson C, O'Fallon W. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999; 42:415-20.
26. Hochberg M, Perlmutter D, Medsger T, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995; 4:454-6.
27. Davies H, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335:547-54.
28. Centers for Disease Control and Prevention. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990; 39(RR-13):33-9.
29. Whitney C, Farley M, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
30. Farley M, Harvey R, Stull T, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993; 328:1807-11.
31. Banerjee S, Emori T, Culver D, et al. Secular trends in nosocomial bloodstream infections in the United States, 1980-1989. Am J Med 1991; 91(suppl 3B):86S-9S.
32. McClelland R, Fowler V, Sanders L, et al. Staphylococcus aureus bacteremia among elderly vs. younger adult patients. Arch Intern Med 1999; 159:1244-7.
33. Mylotte J, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170-4.
34. Willcox P, Rayner B, Whitelaw D. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. QJM 1998; 91:41-7.
35. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6.
36. Laupland KB, Davies HD, Calgary HPTP Study Group. Clinical and microbiologic features and outcome of olecranon septic bursitis managed in an ambulatory setting. Clin Invest Med 2001; 24:171-8.
37. Jensen A, Wachmann C, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia. Arch Intern Med 2002; 162:25-32.
38. Hill PC, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacteremia: determination of factors affecting incidence and mortality. Intern Med J 2001; 31:97-103.
39. Ibrahim E, Sherman G, Ward S, Fraser V, Kollef M. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
40. Valles J, Leon C, Alvarez-Lerma F, Spanish Collaborative Group for infections in intensive care units of Sociedad Espanolade Medecina Intensivay Unidades Coronarias (SEMIUC). Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Clin Infect Dis 1997; 24:387-95.
41. Conterno L, Wey S, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
42. Romero-Vivas J, Fernandez C, Picazo J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21:1417-23.
43. Laupland K, Zygun D, Davies H, Church D, Louie T, Doig C. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate. Crit Care Med 2002; 30:2462-7.